NCT00653042View on ClinicalTrials.gov

Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA

PHASE2CompletedINTERVENTIONAL

Enrollment

305

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

June 30, 2005

Conditions

Coronary Artery Bypass SurgeryCoronary Heart DiseaseCoronary Artery Bypass GraftingCardiopulmonary BypassIschemic Heart DiseaseCongestive Heart Failure

Interventions

DRUG

Nesiritide

All Listed Sponsors

lead

Scios, Inc.

INDUSTRY

NCT00653042 - Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA | Biotech Hunter | Biotech Hunter